Vantage BioTrials
Vantage BioTrials is a Canadian Contract Research Organization founded in 2007 providing Phase I-IV clinical trial management services to pharmaceutical, biotechnology, and medical device sponsors using Quality-by-Design and risk-based monitoring methodologies.
- Company typePrivate
- Founded2007
- HeadquartersSaint Laurent, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Vantage BioTrials does
Vantage BioTrials is a privately held, Canadian-owned Contract Research Organization (CRO) founded in 2007 and headquartered in Montreal, Quebec. The company provides full-service Phase I-IV clinical trial management to pharmaceutical, biotechnology, and medical device sponsors across multiple therapeutic areas including oncology, rare diseases, CNS/pain, cardiology, infectious disease/vaccines, and medical devices. Service offerings span project management, risk-based monitoring (RBM), medical monitoring (including 24/7 SAE/UADE processing and DSMB management), medical writing, biostatistics and data management, quality audits, and a dedicated Site/Study Rescue (SWAT) capability. All services are delivered under a Quality-by-Design (QbD) and Risk-Based Quality Management (RBQM) methodology framework, with operational discipline anchored by an in-house proprietary, validated, web-based Clinical Trial Management System (CTMS) providing real-time KPI, enrollment, SAE, and financial dashboards.
The company's revenue model is professional services-based: multi-year, per-project contracts awarded primarily through RFP processes and direct sponsor engagement, with no tiered or publicly disclosed pricing. Go-to-market is sales-led, with VP Corporate Development Viken Bartekian overseeing business development, portfolio planning, and long-term sponsor partnerships. Customer concentration is diversified across enterprise pharma, biotech, and medical device sponsors, with visible engagements including an AbbVie Phase IV hidradenitis suppurativa trial (enrollment completed 12 months ahead of schedule across 30 Canadian sites) and a pivotal Phase III substance use disorder trial initiated in late 2025. Headcount is reported in the 11-50 range, and the Bartekian family (President Vatché Bartekian, VP Quality Management Vahé Bartekian, VP Corporate Development Viken Bartekian) remains central to leadership.
Recent strategic activity reflects a pivot toward ecosystem participation and AI-enabled capability building. In April 2026 Vantage BioTrials joined the CanReview partner network under the Accelerating Clinical Trials (ACT) Consortium to support a pan-Canadian single research ethics review system, and concurrently entered a multi-institutional scientific collaboration with Sorintellis, Université de Montréal, Université Laval, and IVADO to advance the TrialsBank AI-powered clinical trial intelligence platform. No funding rounds, acquisitions, M&A, or institutional investors have been disclosed, and the company remains family-controlled with no parent company.
Vantage BioTrials firmographics
Firmographics- Name
- Vantage BioTrials
- Legal name
- Vantage BioTrials Inc.
- Website
- https://vantagebiotrials.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vantage BioTrials is a Canadian Contract Research Organization founded in 2007 providing Phase I-IV clinical trial management services to pharmaceutical, biotechnology, and medical device sponsors using Quality-by-Design and risk-based monitoring methodologies.
- Ownership category
- akta.pro rank
Vantage BioTrials industry classification
Industry- Product category
- Clinical Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)
- akta.pro secondary industries
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF)
Keywords
Where Vantage BioTrials is headquartered
LocationHeadquarters
- HQ city
- Saint Laurent
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Vantage BioTrials business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Trial Management Services (Phase I-IV): Full-service CRO providing Phase I-IV clinical trial management to pharmaceutical, biotechnology, and medical device sponsors. Revenue is generated through contracted service fees for project management, monitoring, data management, medical monitoring, regulatory affairs, and quality assurance. Engagement is project-based, typically through RFP/proposals with multi-year trial timelines.
- Specialized Therapeutic Area Services: Deep expertise across multiple therapeutic areas (oncology, rare diseases, CNS, cardiology, medical devices, vaccines, etc.) with specialized services in trial design, site management, endpoint expertise, and regulatory compliance tailored to each indication.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom per-project pricing based on trial scope, phase, and therapeutic area |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Vantage BioTrials product offering
Product offeringCore offering
Vantage BioTrials is a Canadian Contract Research Organization that provides full-service Phase I–IV clinical trial management to pharmaceutical, biotechnology, and medical device sponsors. Its core deliverable is integrated project management, site management, risk-based monitoring, medical monitoring, medical writing, biostatistics and data management, regulatory affairs, and quality assurance, executed under a Quality-by-Design framework and supported by a proprietary web-based Clinical Trial Management System (CTMS).
Product overview
Vantage BioTrials is a Canadian Contract Research Organization (CRO) providing a comprehensive suite of integrated Phase I-IV clinical trial management services. The core offering centers on disciplined clinical trial execution with Quality by Design (QbD) and Risk-Based Monitoring (RBM) methodologies. Services include Project Management, Risk-Based Monitoring/Management, Medical Advising/Monitoring, Medical Writing, Data Services (Biostatistics & Data Management), a proprietary Clinical Trial Management System (CTMS), Quality Management Independent Audits, and Site/Study Rescue capabilities. The company also offers specialized therapeutic area expertise spanning oncology, rare diseases, cardiology, CNS/pain, infectious diseases/vaccines, medical devices/diagnostics, and other indications. All services are delivered through an integrated model emphasizing patient safety, regulatory compliance, and operational excellence.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Management Services Full-service Phase I–IV clinical trial management including project management, site management, risk-based monitoring, medical monitoring, medical writing, data management and biostatistics, regulatory affairs, and quality assurance for pharmaceutical, biotechnology, and medical device sponsors.
- Site/Study Rescue (SWAT) Distinct service in which cross-functional SWATs of senior project managers and clinical monitors are deployed to address poorly performing sites or studies, implementing structured action plans to restore study trajectory and timelines.
- Quality Management Independent Audits Independent quality assurance audits of investigational sites or CROs, including audit report generation, regulatory compliance assessment, GCP/GLP compliance verification, and quality system optimization.
- TrialsBank AI-powered Clinical Trial Intelligence Platform AI-driven intelligence infrastructure for clinical trial decision-making, intended to optimize clinical development across trial design, operational execution, portfolio strategy, valuation, and high-stakes decision-making; co-developed with Sorintellis, Université de Montréal, Université Laval, Mila, and IVADO.
Quantifiable outcome
- Completed AbbVie Phase IV hidradenitis suppurativa trial enrollment accelerated by 12 months with fewer sites than the expected 145 patients across 30 Canadian sites
- +2 more outcomes
Companies that use Vantage BioTrials
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Vantage BioTrials technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Vantage BioTrials partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- CanReview / ACT ConsortiumcoreVantage BioTrials joined the CanReview partner network, a pan-Canadian collaboration supported by the Accelerating Clinical Trials (ACT) Consortium to build a broadly accessible, Canada-wide single research ethics review system enabling all sites participating in a multi-site trial to undergo one ethics review. Collaboration involves Research Ethics Boards, research teams, Indigenous community members, institutions, sponsors, patients and family partners. The initiative aims to enhance clinical trial efficiencies, increase Canada's competitiveness, expand trials to underserved/rural/remote locations, and promote equitable access to trial participation.
- SorintelliscoreStrategic scientific collaboration with Sorintellis, academic experts from Université de Montréal, Université Laval, Mila – Quebec Artificial Intelligence Institute, and IVADO to advance TrialsBank™-powered intelligence infrastructure for clinical trial decision-making. The initiative focuses on developing AI-driven recommendation engines to optimize clinical development across trial design, operational execution, portfolio strategy, valuation, and high-stakes decision-making. Sorintellis leads development of the TrialsBank™ platform.
- Université de MontréalcoreAcademic research partner contributing machine learning models for clinical trial optimization, data standardization for multi-study clinical programs, and scalable AI frameworks for clinical research analytics. Part of the TrialsBank™ collaboration.
- Université LavalcoreAcademic research partner contributing advanced research capabilities to support the TrialsBank™ AI-powered clinical trial intelligence platform. Part of the multi-institutional collaboration with Sorintellis, Université de Montréal, and IVADO.
- IVADO (Institute for Data Valorization)coreIVADO contributes advanced AI and data science expertise to the TrialsBank™ collaboration, supporting machine learning models for clinical trial optimization, data standardization, and scalable AI frameworks for clinical research analytics.
Scale indicators4 records
Expansion highlights4 records
Vantage BioTrials competitors and assessment
Company assessmentDirect peers
- Medpace: Mid-size, science-focused full-service CRO with strong reputation for senior-led trial execution and therapeutic-area specialization — directly comparable business model and target sponsor segment to Vantage BioTrials.
- Premier Research: Specialty CRO with strong rare disease, oncology, and pediatric focus — directly comparable to Vantage BioTrials on therapeutic-area mix and mid-size biotech sponsor base.
- Advanced Clinical: Mid-size clinical research services provider offering full-service CRO and FSP models with therapeutic-area specialization — comparable mid-tier full-service CRO positioning.
- Veristat: Specialty clinical CRO focused on biopharma and rare disease programs with biostatistics and data management capabilities — comparable size, clinical operations/biostatistics mix, and biotech sponsor orientation.
- Altasciences: Canadian-headquartered full-service CRO offering preclinical-to-Phase I/IIa services with Canadian operational footprint — closely comparable geographic base, service mix, and biotech/biopharma sponsor focus to Vantage BioTrials.
- Worldwide Clinical Trials: Mid-size global CRO with therapeutic-area depth in rare diseases, CNS, and oncology; similar mid-tier scale and sponsor-relationship model as Vantage BioTrials.
Broad incumbents
- Parexel: Large global CRO offering full-service Phase I-IV clinical development including medical devices, rare disease and regulatory services — incumbent competitor to Vantage across its core therapeutic areas.
- IQVIA: World's largest CRO and clinical research services provider offering end-to-end Phase I-IV capabilities plus data, technology, and analytics — represents the dominant incumbent Vantage BioTrials competes against for biotech and pharma sponsor work.
- ICON plc: Global full-service CRO formed via PRA Health Sciences merger — Tier-1 incumbent competing with Vantage for biotech and biopharma Phase I-IV engagements across all major geographies.
Others
- Sorintellis: AI/technology partner in the TrialsBank™ collaboration with Vantage BioTrials, developing the underlying clinical-trial AI intelligence platform — relevant as ecosystem/technology partner rather than direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Vantage BioTrials social profiles
Digital presenceVantage BioTrials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vantage BioTrials leadership team
Management profileNumber of profiles
Profiles3 records
Vantage BioTrials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vantage BioTrials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vantage BioTrials
What does Vantage BioTrials do?
Vantage BioTrials is a Canadian Contract Research Organization that provides full-service Phase I–IV clinical trial management to pharmaceutical, biotechnology, and medical device sponsors. Its core deliverable is integrated project management, site management, risk-based monitoring, medical monitoring, medical writing, biostatistics and data management, regulatory affairs, and quality assurance, executed under a Quality-by-Design framework and supported by a proprietary web-based Clinical Trial Management System (CTMS).
Is Vantage BioTrials a public or private company?
Vantage BioTrials is a private company. It is classified as family owned and is currently operating.
When was Vantage BioTrials founded?
Vantage BioTrials was founded in 2007. It employs 11 to 50 people.
Where is Vantage BioTrials based?
Vantage BioTrials is headquartered in Saint Laurent, Canada, in the North America region.
How does Vantage BioTrials make money?
Two revenue lines are on record. Clinical Trial Management Services (Phase I-IV) is the primary driver. The others are specialized Therapeutic Area Services.
Who are Vantage BioTrials's main competitors?
Direct peers on record are Medpace, Premier Research, Advanced Clinical, Veristat, Altasciences and Worldwide Clinical Trials. Broad incumbents are Parexel, IQVIA and ICON plc. Sorintellis is listed as an others.
Does Vantage BioTrials have an API?
No public API is recorded for Vantage BioTrials.
What industry is Vantage BioTrials in?
Vantage BioTrials's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 5417 and its SIC code is 8731.